|
Current Status:
|
|
Cardiologist, Central Cardiology Medical Clinic, 2000-present
|
|
|
|
Certifications:
|
|
Board Certified in Internal Medicine, 1996
|
|
Board Certified in Cardiovascular Disease, 1999
|
|
Board Certified in Interventional Cardiology, 2000
|
|
|
|
Positions:
|
|
Director of Research & Education
Chairman, Health Education and CME Committee
Interventional Cardiologist
Bakersfield Heart Hospital
Bakersfield, CA 93306
|
|
Clinical Instructor in Medicine
David Geffen UCLA School of Medicine
UCLA
Los Angeles, CA
|
|
|
|
Postgraduate Education:
|
|
Fellowships:
|
|
July 1999 - June 2000
Interventional Cardiology Fellowship
Cedars Sinai Medical Center
8700 Beverly Blvd
Los Angeles, CA 90048
|
|
July 1996 - June 1999
Cardiology Fellowship
Division of Cardiology
West Los Angeles VA Medical Center
UCLA School of Medicine
Los Angeles,CA 90073
|
|
Residency:
|
|
July 1994 - June 1996
Department of Medicine
Boston University School of Medicine Combined Residency Program (Boston
University Medical Center, Boston City Hospital and Boston VA Medical Center)
Boston University School of Medicine
Boston, MA
|
|
Oct 1993 - Jun 1994
Department of Medicine
Massachusetts General Hospital
Harvard Medical School
Boston, MA
|
|
Jan 1992-May 1993 (Senior Residency)
Department of Medicine
All India Institute of Medical Sciences
New Delhi-110 023, India
|
|
Jan 1989 - Dec 1991 (Junior Residency)
Department of Medicine
All India Institute of Medical Sciences
New Delhi-110 023, India
Degree: M.D.,Medicine (Postgraduate degree in Medicine)
|
|
|
|
Education:
|
|
1983 - 1988
Medical School: Degree: MBBS
All India Institute of Medical Sciences
New Delhi-110 023, India
|
|
1981 - 1983 Undergraduate Premedical: Degree: Premedical
Multani Mal Modi College and Punjabi University
Patiala 147 002, India
|
|
1970 - 1981
School: Yadavindra Public School
Patiala-147 001, India
|
|
|
|
Awards, Prizes, Scholarships:
|
|
School:
|
|
Merit Prizes in Classes IV, V, VI, VII, VIII and IX for Excellence in
Academics.
|
|
Honor Cards in Classes IV and VII for full attendance.
|
|
Nalagarh Gold Medal for best aggregrate in Mathametics and Science in the
Indian Certificate of Secondary Education (matriculation) in school,1981.
|
|
College:
|
|
Merit Prize for first position in English in PreUniversity class,1981.
|
|
Merit Prize for first position in English, Physics and Chemistry in Premedical
class, 1982.
|
|
First Position in University in Premedical Examination of Punjabi University,
1983. Awarded University Gold Medal by Punjabi University, Patiala, 1983.
|
|
Selected as National Talent Scholar under the National Talent Search Scheme
(100 scholars selected by written test and interview throughout India) by the
National Council of Educational Research and Training(NCERT), New Delhi, 1982.
|
|
Roll of Honor for Excellence in Academics by Multani Mal Modi College, Patiala,
1983.
|
|
First position in entrance examination to Christian Medical College, Ludhiana,
1982.
|
|
Second position in PMT Medical College Entrance examination in Punjab State,
1983.
|
|
Qualified for admission to the MBBS course of the All India Institute of
Medical Sciences, New Delhi on the basis of a competitive written examination
(35 students selected every year from about 40,000 students writing the
examination).
|
|
Medical
School:
|
|
First Prize in Pharmacology.
|
|
Second position in aggregate in Second Professional MBBS.
|
|
First Prize in Gynecology and Obstetrics. Second position in aggregate in Final
Professional MBBS.
|
|
|
|
Research Projects:
|
|
Project: Revascularization comparing surgery versus
percutaneous coronary intervention for unprotected left main artery stenosis
randomized evaluation (REVASCULARIZE) Trial
|
|
Investigators: Raj Makkar, MD and Sanjiv Sharma, MD
Cardiovascular Intervention Center
Cedars Sinai Medical Center, Los Angeles and
Bakersfield Heart Hospital, Bakersfield, CA
|
|
Project: Long term outcome of drug eluting stents in different
patient subsets: diabetes mellitus, acute myocardial infarction and saphenous
vein graft percutaneous coronary intervention.
|
|
Investigators: Raj Makkar, MD and Sanjiv Sharma, MD
Cardiovascular Intervention Center
Cedars Sinai Medical Center, Los Angeles and
Bakersfield Heart Hospital, Bakersfield, CA
|
|
Project: Strategies to prevent slow flow during saphenous vein
graft percutaneous coronary interventions: Intragraft administration of
abciximab and verapamil combined with direct stenting versus traditional PCI
strategies.
|
|
Investigators: Sanjiv Sharma, MD and Raj Makkar, MD
Cardiac Catheterization Laboratories
Bakersfield Heart Hospital, Bakersfield, CA
Cardiovascular Intervention Center
Cedars Sinai Medical Center, Los Angeles and
Bakersfield Heart Hospital, Bakersfield, CA
|
|
Project: Study of the anti-proliferative efficacy of Suramin
in the prevention of experimental in-stent restenosis in a porcine model.
|
|
Investigators: Sanjiv Sharma, MD, and Raj Makkar, MD
Cardiovascular Intervention Center
Cedars Sinai Medical Center
Los Angeles, CA
Grant Appplication for the Braco/Society of Coronary Angiography and
Interventions Grant, 2000.
|
|
Project: Hematopoeitic cell transplantation in experimental
myocardial infarction in a pig model.
|
|
Investigators: Sanjiv Sharma, MD and Raj Makkar, MD
Cardiovascular Intervention Center
Cedars Sinai Medical Center
Los Angeles, CA
|
|
Project: Outcome data on small vessel stenting-a clinical
follow-up study.
|
|
Investigators: Sanjiv Sharma,MD, Neal Eigler, MD and Raj
Makkar, MD
Cardiovascular Intervention Center
Cedars Sinai Medical Center
Los Angeles, CA
|
|
Project: Prediction of hemodynamic significance of
intermediate coronary lesions in coronary arteries of diabetic versus
nondiabetic patients using doppler flow wire.
|
|
Investigators: Sanjiv Sharma,MD and Vishva Dev, MD
West Los Angeles VA Medical Center
UCLA School of Medicine,Los Angeles, CA
1996-1999
|
|
Project: Noninvasive estimation of pulmonary artery wedge
pressure by dual-M-mode echocardiography.
|
|
Investigators: Sanjiv Sharma,MD and Savitri Shrivastava, MD,
DM
Echocardiography Laboratory, Cardiothoracic Center
All India Institute of Medical Sciences, New Delhi, India
Thesis submitted to the All India Institute of Medical Sciences for award of
the postgraduate degree of Medicine, 1991.
1989-1991
|
|
Project: Effect of corticosteroid treatment on various
serological and bronchoalveolar lavage abnormalities in patients with
sarcoidosis.
|
|
Investigators: Sanjiv Sharma,MD and Surender K. Sharma, MD
Bronchoscopy Laboratory, All India Institute of Medical Sciences, New Delhi,
India.
1992
|
|
Project: Relationship between glucocorticoid receptor content
in bronchoalveolar lavage fluid in sarcoidosis and response to steroid
treatment.
|
|
Investigators: Sanjiv Sharma, MD and Surender K. Sharma, MD
Bronchoscopy Laboratory, All India Institute of Medical Sciences, New Delhi,
India.
1992
|
|
|
|
Research Trials:
|
|
COSTAR-II Trial. CObalt chromium STent with Antiproliferative for Restenosis).
Sponsor: ConorMed.
|
|
Revascularization comparing surgery versus percutaneous coronary intervention
for unprotected left main coronary artery stenosis randomized evaluation
(REVASCULARIZE) Trial.
|
|
ASSENT 4 PCI-Assessment of the safety and efficacy of a new treatment strategy
for acute myocardial infarction. Sponsor: Genentech.
|
|
Drug eluting stent Cover Registry. Sponsor: Cordis / Johnson & Johnson.
|
|
TRITON-TIMI 38-A comparison of CS-747 and clopidogrel in acute coronary
syndrome patients undergoing PCI; a phase III, multicenter, radomized,
parallel-group, double-blind, double-dummy, active controlled trial. Sponsor:
TIMI Trials group.
|
|
TITAN-TIMI 34-Time to Integrilin therapy in acute myocardial infarction.
Sponsor: TIMI Trials group.
|
|
Multicenter, randomized double blind placebo controlled efficacy and safety
study to evaluate the effects of Tolvaptan (OPC-41061) on the chronic outcomes
of patients with congestive heart failure. Sponsor: Otsuka.
|
|
REVIVE (Ranomized, multicenter Evaluation of intravenous Levosimendan efficacy
versus placebo in the short term treatment of decompensated congestive heart
failure). Sponsor: Orion.
|
|
A double blind randomized placebo controlled parrallel group multicenter
flexible dose study to evaluate the efficacy and safety of Viagra (sildenafil
citrate) in males with erectile dysfunction and coronary artery disease.
Sponsor: Pfizer.
|
|
ATBAT Study-Anticoagulant therapy with bivalirudin to assist in the performance
of percutaneous intervention in patients with heparin induced thrombocytopenia.
Sponsor: The Medicines Company.
|
|
A double blind randomized placebo controlled parrallel group multicenter
flexible dose study to evaluate the efficacy and safety of Viagra (sildenafil
citrate) in males with erectile dysfunction and congestive heart failure.
Sponsor: Pfizer.
|
|
Vasopressin inhibition with Tolvaptan assessment of long term efficacy (VITAL
study) Sponsor: Otsuka
|
|
Clinical utility of Amlodipine/Atorvastatin to improve concomitant
cardiovascular risk factors of hypertension and dyslipidemia (GEMINI study).
Sponsor: Pfizer
|
|
WATCH-Warfarin and antiplatelet therapy in chronic heart failure.
|
|
RITZ 2-Tezosentan in congestive heart failure.
|
|
An open-label, community-based clinical practice study of Niaspan in patients
with hyperlipidemia.
|
|
REACH registry-Reduction of atherothrombosis for continued health.
|
|
ADVANCE MI-Adressing the value of primary angioplasty after combination therapy
or eptifibatide monotherapy in acute myocardial infarction.
|
|
EVEREST-Multi-center, randomized, double-blind, placebo-controlled study to
evaluate the long term efficacy and safety of oral Tolvaptan in subjects
hospitalized with worsening congestive heart failure.
|
|
IRIS-A 6-week, randomized, open-label, comparative study to evaluate the
efficacy and safety of rosuvastatin and atorvastatin in the treatment of
hypercholesterolemia in South Asian subjects.
|
|
EARLY ACS-Early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation
acute coronary syndrome; a randomized, placebo-controlled trial evaluating the
clinical benefits of early front-loaded eptifibatide in the treatment of
patients with non-ST-segment elevation acute coronary syndromes.
|
|
ALT-711-Effect of Alagebrium in combination with fixed-dose hydrochlorthiazide
therapy on systolic blood pressure in hypertensive patients.
|
|
PRIMO-CABG II- A multicenter, randomized, double-blind, parallel-group,
placebo-controlled infusion of Pexelizumab in patients undergoing CABG with
cardiopulmonary bypass.
|
|
AHEAD- Achieve hypertension efficacy with AMEAL S dietary supplement.
|
|
|
|
Publications:
|
|
Sharma S, Bhambi B. Successful treatment of hypotension associated with stunned
myocardium with oral midodrine therapy. J Cardiovasc Pharmacol Ther. 2005;10:
77-9.
|
|
Sharma S, Makkar RR, Bhambi B, Nyitray W, Desai K, Ishimori T. Intragraft
administration of abciximab and verapamil combined with direct stenting
prevents slow-flow and no-reflow phenomena in saphenous vein graft percutaneous
coronary interventions. Catheter Cardiovasc Interv 2005; 65 B:119.B 43
(abstract).
|
|
Sharma S, Bhambi B. Vertebral artery stenting utilizing distal embolic
protection withy Filter Wire and a drug eluting Taxus stent. (submitted)
|
|
Sharma S, Makkar RR,Lardizabal J. Intracoronary administration of abciximab
(ReoPro) during percutaneous coronary interventions (PCI)-should this be the
routine and preferred approach? (submitted)
|
|
Sharma S, Lardizabal J, Nyitray W, Florence M, File C, Roland M. Mitral
Regurgitation Is A Prevalent Phenomenon In Patients With "lone" Atrial
Afibrillation And May Be A Risk Factor For Causing "lone" Atrial Fibrillation.
(submitted).
|
|
Sharma S, Nyitray W, Bhambi B.Glycoprotein IIb/IIIa inhibition in percutaneous
coronary interventions. JAMA. 2003; 290:1451.
|
|
Sharma S, Bhambi B, Nyitray W, Desai K, Davis D, Sharma G, Shukla P, File C,
Ishimori T. Bivalirudin (Angiomax) use during intracoronary brachytherapy may
predispose to acute closure. J Cardiovasc Pharmacol Ther 2003; 8:9-15.
|
|
Sharma S, Forrester J, Makkar RM. The SOS study comparing coronary artery
bypass graft surgery (CABG) with stenting. Lancet 2003; 361:614-5.
|
|
Sharma S, Bhambi B, Nyitray W. Sirolimus-eluting coronary stents. N Engl J Med
2002; 347: 1285.
|
|
Sharma S, Nyitray W, Bhambi B. Brachytherapy and saphenous vein grafts. N Engl
J Med 2002; 347: 692.
|
|
Sharma S, Bhambi B, Ishimori T. A better control for ICD patients? Eur Heart J
2002; 23:1972.
|
|
Sharma S, Bhambi B, Nyitray W, Desai K, Sharma G, Shukla P, Antonescu A, Denny
E, Richardson K, Sadberry R, Ishimori T. Intragraft administration of abciximab
and verapamil combined with direct stenting prevents slow-flow during saphenous
vein graft percutaneous coronary interventions. Am J Cardiol 2002; 154 H.
|
|
Sharma S, Bhambi B, Nyitray W, Sharma G, Shambaugh S, Antonescu A, Shukla P,
Denny E. Delayed profound thrombocytopenia presenting 7 days after use of
abciximab (ReoPro). J Cardiovasc Pharmacol Ther 2002; 7(1):21-24.
|
|
Sharma S, Makkar RM. Percutaneous Intervention on the LIMA -tackling the
tortuosity. J Invasive Cardiol. 2003;15:359-62.
|
|
Sharma S. Miscellaneous medical complications in pregnancy. Obstetrics
Gynaecology Today, 1999; 4:259-261.
|
|
Sharma S. Thromboembolic disorders in pregnancy and puerperium. Obstetrics
Gynaecology Today, 1999;4:324.
|
|
Sharma S, Eagle KA. Monitoring the pulmonary artery wedge pressure in medical
patients: value, limitations and complications. Am Fam Physician 1996;
54:1039-49.
|
|
Sharma SK, Khanna M, Sharma S, Srivastava LM, Verma K, Khilnani GC, Pande JN.
Effect of corticosteroid treatment on various serological and bronchoalveolar
lavage abnormalities in patients with sarcoidosis. Indian J Med Res 1995;101:
207-12.
|
|
Sharma SK, Vij U, Sharma S, Murugasen K, Verma K, Pande JN. Glucocorticoid
receptor content in bronchoalveolar lavage fluid in sarcoidosis and its
relevance to steroid treatment. Am J Respir Crit Care Med 1994; 148: A 606
(abstract).
|
|
Sharma S, Goswami KC,Shrivastava S,Sharma SK. Noninvasive estimation of
pulmonary artery wedge pressure by dual -M- mode echocardiography. J Assoc
Physicians India 1994; 42:298-99.
|
|
Khilnani GC, Sharma SK, Sharma S, Srivastava LM, Verma K, Khanna M, Pande JN.
Effect of corticosteroid treatment on various serological and bronchoalveolar
lavage abnormalities in patients with sarcoidosis. Am Rev Respir Dis 1993; 147
:A 89 (abstract).
|
|
Sharma S, Wasir HS. Myocardial revascularization in acute myocardial
infarction. J Assoc Physicians India 1993; 41:103-109.
|
|
Sharma SK, Sharma S, Mukhopadhyay S. Mediastinal paraganglioma presenting as an
intracardiac mass with superior vena cava obstruction. Thorax 1993; 48:1181-82.
|
|
Sharma S, Goswami KC, Shrivastava S, Sharma SK. Noninvasive estimation of
pulmonary artery wedge pressure by dual -M- mode echocardiography. Indian Heart
J 1992; 44:281 (abstract).
|
|
Sharma SK, Sharma S, Mukhopadhyay S, Padhy AK, Vijayaraghavan M. Pulmonary
alveolar microlithiasis. Indian J Chest Dis Allied Sci 1992;34: 205-15.
|
|
Sharma JB, Buckshee K, Sharma S. Puberty menorrhagia due to Bernard Soulier
syndrome and its successful treatment by Ovral hormonal tablets. Aust N Z J
Obstet Gynaecol 1991;31:369-70.
|
|
Ramesh V, Tanwar RK, Kaushal R, Vaid ,Rath GK, Gupta R, Sharma S, Choubey RP.
Oesophageal carcinoma in association with Non-Hodgkin's lymphoma. J Inst
Medicine 1991;13: 296-300.
|
|
Sharma JB, Tiwari S, Gulati N, Sharma Sanjiv. Schmidt's syndrome : a rare cause
of puberty menorrhagia. International J Gynecology Obstetrics 1990;33: 373-75.
|
|
|
|
Book Chapters:
|
|
Sharma Sanjiv. Medical Complications in Pregnancy. In Sharma JB. The Obstetric
Protocol. New Delhi, Jaypee Brothers,1998, Pp 75-148.
|
|
|
|
Editorial Board:
|
|
Manuscript Reviewer, The Lancet,London,United Kingdom.
|
|
Manuscript Reviewer: The Journal of Cardiovascular Pharmacology and
Therapeutics, Los Angeles, CA
|
|
Consulting Editor, Obstetrics Gynaecology Today, New Delhi, India.
|
|
|
|
Consultancies:
|
|
Consultant to the Central Complaint Unit of the Medical Board of California,
Sacramento,CA. 2005-now. Responsibilties include reviewing medical records in
complaints and malpractice cases filed against physicians and providing expert
opinion and recommendations to the Medical Board of California.
|
|
Invited by the American Board of Internal Medicine (ABIM) to review questions
set for the American Board of Internal Medicine (ABIM) Interventional
Cardiology Certification Examination, 2005.
|
|
Invited by the American Board of Internal Medicine (ABIM) to set questions for
the. American Board of Internal Medicine (ABIM) Cardiovascular Disease
Re-certification Examination, 2002.
|
|
Invited by the American Board of Internal Medicine (ABIM) to review questions
set for the American Board of Internal Medicine (ABIM) Cardiovascular Disease
Re-certification Examination, 2001.
|
|
Director of Research & Education, Bakersfield Heart Hospital, Bakersfield, CA
2003-now.
|
|
Member, Institutional Research Board (IRB) Committee, Bakersfield Heart
Hospital, Bakersfield, CA 2001
|
|
|
|
Original Inventions, Procedures and Patents:
|
|
New atraumatic guiding catheter for coronary angioplasty: Patent to be filed in
the future. This invention allows cannulation of the coronary arteries without
any trauma and is proposed to reduce the likelihood of guide induced trauma
during angioplasty.
|
|
New percutaneous coronary intervention technique for treatment of saphenous
vein bypass grafts utilizing intragraft administration of abciximab and
verapamil combined with direct stenting to prevent slow-flow and no-reflow
phenomenon.
|
|
New percutaneous coronary intervention technique for treatment of tortuous
internal mammary artery bypass graft.
|
|
|
|
Conference Presentations:
|
|
Intragraft administration of abciximab and verapamil combined with direct
stenting prevents slow-flow and no-reflow phenomena in saphenous vein graft
percutaneous coronary interventions. Society of Cardiac Angiography and
Interventions. Ponte Vedra Beach, FL. May 2005.
|
|
Intragraft administration of abciximab and verapamil combined with direct
stenting prevents slow-flow during saphenous vein graft percutaneous coronary
interventions. Presented at the Transcatheter Cardiovascular Therapeutics,
Washington DC 2002.
|
|
Intravascular Brachytherapy with Rhenium-188 balloon: Radiant Pilot Study.
Presented at the American College of Cardiology Meeting, Anaheim, CA 2000.
|
|
Glucocorticoid receptor content in bronchoalveolar lavage fluid in sarcoidosis
and its relevance to steroid treatment. Presented at the American Thoracic
Society Meeting, Boston, MA 1994.
|
|
Effect of corticosteroid treatment on various serological and bronchoalveolar
lavage abnormalities in patients with sarcoidosis. Presented at the American
Thoracic Society Meeting , San Francisco, CA 1993.
|
|
Noninvasive estimation of pulmonary artery wedge pressure by dual -M- mode
echocardiography. Presented at the 44 th Annual Conference of the Cardiological
Society of India, New Delhi, India 1992.
|
|
Spectrum of myelodysplastic syndrome in India. Presented at the XXX Annual
Conference of the Indian Society of Hematology and Blood Transfusion,
Berhampur, India 1989.
|
|
|
|
Invited Presentations and Lectures:
|
|
Approach to Coronary artery disease and Acute Coronary Syndromes. Kern Valley
Hospital, Lake Isabella, CA. December 2002.
|
|
Drug-Eluting Coronary Stents: Update on data from SIRIUS-400 and TAXUS trials.
Cardiac Catheterization Conference, Bakersfield Heart Hospital, Bakersfield, CA
October 2002.
|
|
Management of Acute Coronary Syndromes. Dept. of Family Practice Conference,
Kern Medical Center, Bakersfield, CA September, 2002.
|
|
Drug-Eluting Coronary Stents: Basic design, mechanisms and review of RAVEL
study. Cardiac Catheterization Conference, Bakersfield Heart Hospital,
Bakersfield, CA August 2002.
|
|
Approach to Acute Coronary Syndromes. Nurses Conference, Bakersfield Memorial
Hospital, Bakersfield, CA September 2001.
|
|
Approach to chest pain syndromes. Nurse Practitioner Course Lecture series.
California State University Bakersfield, Bakersfield, CA April 2001.
|
|
Post Angioplasty Care from a nursing perspective. Cardiac Care Nurses
Conference. Bakersfield Heart Hospital, Bakersfield, CA March 2001.
|
|
Interventional Cardiology Update. Dept. of Medicine Conference. Kern Medical
Center, Bakersfield, CA.October 2000.
|
|
Technical considerations in Internal Mammary Artery (IMA) Coronary
Interventions. Cardiac Catheterization Conference. Cedars Sinai Medical Center,
Los Angeles, CA June 2000.
|
|
Percutaneous Cardiopulmonary Bypass Support (PCPS) and PCPS-supported high risk
angioplasty. Cardiac Catheterization Conference. Cedars Sinai Medical Center,
Los Angeles, CA May 2000.
|
|
Cardiac Allograft Vasculopathy. Cardiac Catheterization Conference, Cedars
Sinai Medical Center, Los Angeles. February 2000.
|
|
Management of Isolated Left Anterior Descending coronary artery disease-
Angioplasty vs. Stent vs. bypass surgery. Interventional Cardiology Journal
Club Rounds. Cedars Sinai Medical Center, Los Angeles, CA February 2000.
|
|
Pulmonary artery catheterization. Dept. of Medicine Conference. Kern Medical
Center, Bakersfield, CA February 2000.
|
|
Cilostazol and restenosis after coronary stenting: review of studies.
Interventional Cardiology Journal Club Rounds. Cedars Sinai Medical Center, Los
Angeles, CA December 1999.
|
|
Percutaneous Coronary Interventions for Saphenous Vein Graft Disease. Cardiac
Catheterization Conference. Cedars Sinai Medical Center, Los Angeles, CA
November 1999.
|
|
Neointimal Hyperplasia and mechanisms of instent restenosis after coronary
stenting procedures. Interventional Cardiology Journal Club Rounds. Cedars
Sinai Medical Center, Los Angeles, CA November 1999.
|
|
Spontaneous Coronary Dissection. Cardiac Catheterization Conference, Cedars
Sinai Medical Center, Los Angeles, CA October 1999.
|
|
Qunatitative Coronary Angiography (QCA) of Stent Restenosis in SCRIPPS Trial.
Interventional Cardiology Journal Club Rounds. Cedars Sinai Medical Center, Los
Angeles, CA September 1999.
|
|
Angioplasty and stenting of the left main coronary artery. Cardiac
Catheterization Conference. Cedars Sinai Medical Center, Los Angeles, CA August
1999.
|
|
Primary Stenting Versus Balloon Angioplasty in Occluded Coronary Arteries: The
Total Occlusion Study of Canada. Interventional Cardiology Journal Club Rounds.
Cedars Sinai Medical Center, Los Angeles, CA August 1999.
|
|
Effectiveness of Clopidogrel and Aspirin versus Ticlopidine and Aspirin in
stent implantation. Interventional Cardiology Journal Club Rounds. Cedars Sinai
Medical Center, Los Angeles, CA July 1999.
|
|
Pharmacology of the Thienopyridine derivatives, Ticlopidine and Clopidogrel, in
relation to coronary stenting procedures. Interventional Cardiology Journal
Club Rounds. Cedars Sinai Medical Center, Los Angeles, CA July 1999.
|
|
Randomized clinical trials of Coronary Artery Bypass Graft versus Percutaneous
Transluminal Coronary Angioplasty. Cardiology Grand Rounds. West Los Angeles VA
Medical Center,Los Angeles, CA June 1999.
|
|
Stenting of Unprotected Left Main Coronary Artery Stenoses: Immediate and Late
Outcomes. Cardiology Journal Club Rounds. Oliveview-UCLA Medical Center, Los
Angeles, CA February 1998.
|
|
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in
Patients Resuscitated from Near-Fatal Ventricular Arrhythmias: AVID Trial.
Cardiology Journal Club Rounds. West Los Angeles VA Medical Center, Los
Angeles, CA December 1997.
|
|
Prediction of hemodynamic significance of intermediate coronary lesions in
coronary arteries of diabetic versus nondiabetic patients using doppler flow
wire. Research Conference. West Los Angeles VA Medical Center, Los Angeles, CA
November 1997.
|
|
Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during
Percutaneous Coronary Revascularization: EPILOG Study. Cardiology Journal Club
Rounds. West Los Angeles VA Medical Center, Los Angeles, CA June 1997.
|
|
Management of Hypertension. Graduating Senior Resident Talk. Boston University
School of Medicine Residency Program, Boston, MA June 1996.
|
|
Myocardial revascularization in acute myocardial infarction. Dept of Medicine
Journal Club Rounds. All India Institute of Medical Sciences, New Delhi, India.
1990.
|
|
Mediastinal paraganglioma presenting as an intracardiac mass with superior vena
cava obstruction. Medical Grand Rounds, All India Institute of Medical Sciences
(AIIMS), New Delhi, India, 1990.
|
|
Pulmonary alveolar microlithiasis. Medical Grand Rounds. All India Institute of
Medical Sciences, New Delhi, India. 1989.
|
|
New Treatment strategies in the management of Bronchial Asthma. Dept of
Medicine Journal Club Rounds, All India Institute of Medical Sciences, New
Delhi, India. 1989.
|
|
|
|
Memberships of Societies:
|
|
Fellow, Society of Cardiac Angiography and Interventions, 2003.
|
|
Fellow of the American College of Cardiology (FACC), 2002.
|
|
Member, American Heart Association Council on Cardiovascular Radiology and
Intervention, 2002.
|
|
Member, American Heart Association Council on Clinical Cardiology, 2000.
|
|
Member, American Medical Association, 2000.
|
|
Member, California Medical Association, 2000.
|
|
Member, Kern County Medical Society, 2000.
|
|
Affiliate Member, Society of Cardiac Angiography and Interventions, 2000.
|
|
Associate Fellow-in-Training, American College of Cardiology, 1996
|
|
Member, American Academy for Advancement of Science (by invitation), 1994.
|
|
Member, The Massachusetts Medical Society,1994.
|
|
|
|
Medical License:
|
|
Medical Board of California : A 056149
|
|
Commonwealth of Massachusetts Board of Medicine: 82219
|
|
Federal DEA license.
|
|
Passed FLEX in Pennsylvania,1993.
|
|
|
|
Examinations:
|
|
Board Certified in Internal Medicine by the American Board of Internal Medicine
(ABIM). Passed the American Board of Internal Medicine (ABIM) Certification
Examination, 1996 with 10th decile scores.
|
|
Board Certified in Cardiovascular Disease, by the American Board of Internal
Medicine (ABIM). Passed the American Board of Internal Medicine (ABIM)
Certification Examination, 1999 with 10th decile scores.
|
|
Board Certified in Interventional Cardiology, by the American Board of Internal
Medicine (ABIM). Passed the American Board of Internal Medicine (ABIM)
Certification Examination, 2000 with 10th decile scores.
|
|
FMGEMS SCORES
Part I : 91
Part II : 93
|
|
FLEX SCORES
Part I : 91
Part II : 87
|
|
|
|
Professional Experience:
|
| Procedures |
Number
of Cases |
Percutaneous Intervention (PCI) procedures
(including balloon angioplasty, stents, Rotational atherectomy, Excimer Laser
Coronary Angioplasty, Angiogjet thrombectomy, Intravascular Ultrasound (IVUS),
Peripheral angioplasty stent and atherectomy procedures, Carotid Stent, Septal
alcohol ablation for HOCM)
|
~1000 |
Diagnostic Left and Right Heart Catheterizations
(including Coronary Angiography, left ventriculography, Aortography,
Endomyocardial biopsies, Temporary Pacemaker, Intraaortic balloon pump)
|
~4000 |
|
Transesophageal Echocardiograms (TEE)
|
~500 |
|
Transthoracic Echocardiograms
|
>4500 |
Stress tests
(including nuclear studies, Dobutamine echo)
|
~1500 |
Cardioversions
|
~100 |
|
|
|
|
DISCLAIMER: This web site and information is provided for general information
only and is not a substitute for professional medical advice. We are not
responsible or liable for any diagnosis or action made by a user based on the
content of this web site. |
© 2004 Central Cardiology Medical Clinic. All Rights Reserved. |
Tetsuo Ishimori, MD
